Literature DB >> 17711860

Co-receptor requirements for fibroblast growth factor-19 signaling.

Xinle Wu1, Hongfei Ge, Jamila Gupte, Jennifer Weiszmann, Grant Shimamoto, Jennitte Stevens, Nessa Hawkins, Bryan Lemon, Wenyan Shen, Jing Xu, Murielle M Veniant, Yue-Sheng Li, Richard Lindberg, Jin-Long Chen, Hui Tian, Yang Li.   

Abstract

FGF19 is a unique member of the fibroblast growth factor (FGF) family of secreted proteins that regulates bile acid homeostasis and metabolic state in an endocrine fashion. Here we investigate the cell surface receptors required for signaling by FGF19. We show that betaKlotho, a single-pass transmembrane protein highly expressed in liver and fat, induced ERK1/2 phosphorylation in response to FGF19 treatment and significantly increased the interactions between FGF19 and FGFR4. Interestingly, our results show that alphaKlotho, another Klotho family protein related to betaKlotho, also induced ERK1/2 phosphorylation in response to FGF19 treatment and increased FGF19-FGFR4 interactions in vitro, similar to the effects of betaKlotho. In addition, heparin further enhanced the effects of both alphaKlotho and betaKlotho in FGF19 signaling and interaction experiments. These results suggest that a functional FGF19 receptor may consist of FGF receptor (FGFR) and heparan sulfate complexed with either alphaKlotho or betaKlotho.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17711860     DOI: 10.1074/jbc.C700130200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.

Authors:  Johanna H M Stroeve; Gemma Brufau; Frans Stellaard; Frank J Gonzalez; Bart Staels; Folkert Kuipers
Journal:  Lab Invest       Date:  2010-06-07       Impact factor: 5.662

Review 2.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine.

Authors:  Matthew J Potthoff; Steven A Kliewer; David J Mangelsdorf
Journal:  Genes Dev       Date:  2012-02-02       Impact factor: 11.361

Review 3.  Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

4.  C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors.

Authors:  Xinle Wu; Bryan Lemon; XiaoFan Li; Jamila Gupte; Jennifer Weiszmann; Jennitte Stevens; Nessa Hawkins; Wenyan Shen; Richard Lindberg; Jin-Long Chen; Hui Tian; Yang Li
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

5.  Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.

Authors:  Xinle Wu; Hongfei Ge; Bryan Lemon; Jennifer Weiszmann; Jamila Gupte; Nessa Hawkins; Xiaofan Li; Jie Tang; Richard Lindberg; Yang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

6.  Instability restricts signaling of multiple fibroblast growth factors.

Authors:  Marcela Buchtova; Radka Chaloupkova; Malgorzata Zakrzewska; Iva Vesela; Petra Cela; Jana Barathova; Iva Gudernova; Renata Zajickova; Lukas Trantirek; Jorge Martin; Michal Kostas; Jacek Otlewski; Jiri Damborsky; Alois Kozubik; Antoni Wiedlocha; Pavel Krejci
Journal:  Cell Mol Life Sci       Date:  2015-02-18       Impact factor: 9.261

Review 7.  Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis.

Authors:  Lucas D BonDurant; Matthew J Potthoff
Journal:  Annu Rev Nutr       Date:  2018-05-04       Impact factor: 11.848

Review 8.  Fifty years of advances in bile acid synthesis and metabolism.

Authors:  David W Russell
Journal:  J Lipid Res       Date:  2008-09-24       Impact factor: 5.922

9.  Relevant use of Klotho in FGF19 subfamily signaling system in vivo.

Authors:  Ken-ichi Tomiyama; Ryota Maeda; Itaru Urakawa; Yuji Yamazaki; Tomohiro Tanaka; Shinji Ito; Yoko Nabeshima; Tsutomu Tomita; Shinji Odori; Kiminori Hosoda; Kazuwa Nakao; Akihiro Imura; Yo-ichi Nabeshima
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

10.  Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis.

Authors:  Xinle Wu; Yang Li
Journal:  Aging (Albany NY)       Date:  2009-12-09       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.